PRIME Care Study
WEBINAR: Incorporating Pharmacogenomics into your Clinical Mental Health Practice
This webinar was presented by the VISN 4 MIRECC, the National Pharmacogenomics Program, and the VA Institute for Learning, Education, and Development (ILEAD). Intended Audience: physicians, psychologists, nurses/advanced practice nurses, pharmacists, physician assistants, social workers, licensed independent counselors. If you would like to view a full recording of this April 2023 program, please email our team. Please note that Continuing Education credits are not available when viewing the recording.
WEBINAR: Pharmacogenetics Trial of Depression: A Focus on Suicidal Thoughts
This VA Health Services Research & Development presentation led by PRIME Care principal investigator and VISN 4 MIRECC director David Oslin, M.D. provides an overview of the PRIME Care study including aims and progress to date and explains the research team's process for addressing suicidal ideation, rates of suicidal ideation and time-dependent changes in suicidal thoughts. Intended Audience: Research community. September 21, 2020
WEBINAR: Precision Medicine in Mental Health Care: Can Pharmacogenomic Testing Improve Antidepressant Outcomes?
This presentation led by Michael Thase, M.D. of the VISN 4 MIRECC reviews the current gaps in antidepressant prescribing and examines whether systematic use of pharmacogenomic testing can improve treatment outcomes. If you would like to view a full recording of this March 2019 presentation, email our team. Please note that Continuing Education credits are not available when viewing the recording.
WEBINAR: Precision Medicine in Mental Health Care: Incorporating Implementation Science into a Large-Scale RCT
This VA Health Services Research & Development Spotlight on Mental Health Centers of Excellence presentation led by PRIME Care principal investgator and VISN 4 MIRECC director David Oslin, M.D. and Center for Integrated Healthcare director Laura Wray, Ph.D., summarizes how the PRIME Care project incorporates implementation science methodology to support the trial and prepare for rapid implementation if the intervention proves to be effective. Intended Audience: anyone interested in how VA is evaluating and preparing for future use of PGx, including researchers, providers, and policy makers. December 10, 2018
VIDEO: Introduction to Pharmacogenetics: PRIME Care Study: https://youtu.be/X5atvMqPAUY
Intended Audience: Patients and Providers
VIDEO: Welcome to PRIME Care! https://youtu.be/lWan85T5Q_g
This video provides an overview of the Precision Medicine in Mental Health Care (PRIME Care) study.
Running time: 2:17
Intended Audience: Patients
VIDEO: PRIME Care Study Introduction: https://youtu.be/U_TXIWypb6E
This video summarizes the VA PRIME Care study, including public health significance, study design, the pharmacogenetic test used, study hypotheses, and future directions.
Running time: 21:59
Intended Audience: Providers
VIDEO: Introduction to Pharmacogenetic Testing for Providers: https://youtu.be/h6MbeaEUNn0
This video provides an introduction to pharmacogenetics and discusses the potential application of pharmacogenetics to the mental health field. An overview of the VA PRIME Care study is presented.
Running time: 5:42
Intended Audience: Providers
VIDEO: Using Your Patient Test Results: https://youtu.be/qOsAxI0uOPA
Utilizing four case examples, this video walks through the application of pharmacogenetic test results used in the VA PRIME Care Study.
Running time: 14:47
Intended Audience: Providers
VIDEO: Talking to Your Patients About Test Results: https://youtu.be/1TmqoG16lJI
Through the use of vignettes, this video provides guidance to providers on how to talk to their patients about the pharmacogenetic test used in the VA PRIME Care study and approaches for reviewing the results.
Running time: 15:01
Intended Audience: Providers
VA PRIME Care Playlist: https://www.youtube.com/playlist?list=PL3AQ_JVoBEyyRPLVhZ8NjgL9J3HU4jZ4d
ClinicalTrials.gov ID: NCT03170362
